ArticleTheranostics2021

Generation of triacyl lipopeptide-modified glycoproteins by metabolic glycoengineering as the neoantigen to boost anti-tumor immune response.

Yujia Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.